TY - JOUR
T1 - Disparities in Telehealth Care in Multiple Sclerosis
AU - Marrie, Ruth Ann
AU - Kosowan, Leanne
AU - Cutter, Gary
AU - Fox, Robert
AU - Salter, Amber
N1 - Funding Information:
R.A. Marrie: receives research funding from the CIHR, MS Society of Canada, MS Scientific Research Foundation, National MS Society, Crohns and Colitis Canada, the US Department of Defense, and the CMSC and is supported by the Waugh Family Chair in Multiple Sclerosis. L. Kosowan: nothing to disclose. G. Cutter: data/safety monitoring committees for AMO, BioLineRx, BrainStorm Cell Therapeutics, Galmed, Horizon, Hisun, Merck, Merck/Pfizer, OPKO Biologics, Neurim, Novartis, Orphazyme, Sanofi, Reata, Receptos/Celgene, Teva, NHLBI (Protocol Review Committee), and NICHD (OPRU oversight committee), and consulting/advisory boards for Biogen, Click Therapeutics, Genzyme, Genentech, GW, Klein Buendel, MedImmune, MedDay, Novartis, Osmotica, Perception Neuroscience, Recursion, Roche, Somahlution, and TG Therapeutics. R. Fox: consulting fees from AB Science, Actelion, Biogen, Celgene, EMD Serono, Genentech, Immunic, Novartis, Sanofi, and TG Therapeutics; advisory committees for Actelion, Biogen, Immunic, Novartis, and Sanofi; and research grant funding from Novartis. A. Salter: journal editor/member of editorial advisory board for Circulation: Cardiovascular Imaging. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp .
Funding Information:
NARCOMS is a project of the Consortium of Multiple Sclerosis Centers (CMSC). NARCOMS is funded in part by the CMSC and the Foundation of the CMSC. The study was also supported in part by the Waugh Family Chair in Multiple Sclerosis and Research Manitoba Chair (to RAM).
Publisher Copyright:
© American Academy of Neurology.
PY - 2022/6/1
Y1 - 2022/6/1
N2 - Background and ObjectivesThe COVID-19 pandemic has dramatically increased telehealth use. We assessed access to and use of telehealth care, including videoconferencing and usability of videoconferencing, among persons with multiple sclerosis (MS).MethodsIn Fall 2020, we surveyed participants in the North American Research Committee on Multiple Sclerosis Registry. Participants reported availability and receipt of MS care or education through telehealth. Participants who completed ≥1 live videoconferencing visit completed the Telehealth Usability Questionnaire (TUQ). We tested factors associated with access to and receipt of telehealth care using logistic regression. We tested factors associated with TUQ scores using quantile regression.ResultsOf the 8,434 participants to whom the survey was distributed, 6,043 responded (71.6%); 5,403 were eligible for analysis. Of the respondents, 4,337 (80.6%) were women, and they had a mean (SD) age of 63.2 (10.0) years. Overall, 2,889 (53.5%) reported access to MS care via telehealth, and 2,110 (39.1%) reported receipt of MS care via telehealth including 1,523 (28%) via videoconference. Among participants who reported telehealth was available, older age was associated with decreased odds of having a telehealth video visit; higher income and being physically active were associated with increased odds. Older age and moderate to very severe visual symptoms were associated with lower perceived usability of telehealth.DiscussionOlder age, lower socioeconomic status, and disease-related impairments are associated with less access to and use of telehealth services in people with MS. Barriers to telehealth should be addressed to avoid aggravating health care disparities when using digital medicine.
AB - Background and ObjectivesThe COVID-19 pandemic has dramatically increased telehealth use. We assessed access to and use of telehealth care, including videoconferencing and usability of videoconferencing, among persons with multiple sclerosis (MS).MethodsIn Fall 2020, we surveyed participants in the North American Research Committee on Multiple Sclerosis Registry. Participants reported availability and receipt of MS care or education through telehealth. Participants who completed ≥1 live videoconferencing visit completed the Telehealth Usability Questionnaire (TUQ). We tested factors associated with access to and receipt of telehealth care using logistic regression. We tested factors associated with TUQ scores using quantile regression.ResultsOf the 8,434 participants to whom the survey was distributed, 6,043 responded (71.6%); 5,403 were eligible for analysis. Of the respondents, 4,337 (80.6%) were women, and they had a mean (SD) age of 63.2 (10.0) years. Overall, 2,889 (53.5%) reported access to MS care via telehealth, and 2,110 (39.1%) reported receipt of MS care via telehealth including 1,523 (28%) via videoconference. Among participants who reported telehealth was available, older age was associated with decreased odds of having a telehealth video visit; higher income and being physically active were associated with increased odds. Older age and moderate to very severe visual symptoms were associated with lower perceived usability of telehealth.DiscussionOlder age, lower socioeconomic status, and disease-related impairments are associated with less access to and use of telehealth services in people with MS. Barriers to telehealth should be addressed to avoid aggravating health care disparities when using digital medicine.
UR - http://www.scopus.com/inward/record.url?scp=85132338113&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132338113&partnerID=8YFLogxK
U2 - 10.1212/CPJ.0000000000001167
DO - 10.1212/CPJ.0000000000001167
M3 - Article
C2 - 35747551
AN - SCOPUS:85132338113
SN - 2163-0402
VL - 12
SP - 223
EP - 233
JO - Neurology: Clinical Practice
JF - Neurology: Clinical Practice
IS - 3
ER -